期刊文献+

中药雾化吸入配合化疗治疗晚期非小细胞肺癌的临床观察 被引量:2

Clinical study of TCM nebulized inhalation combined with radio chemotherapy for non-small cell lung cancer
下载PDF
导出
摘要 目的观察中药雾化吸入配合化疗治疗晚期非小细胞肺癌(NSCLC)的临床疗效。方法将60例晚期非小细胞肺癌患者按随机数字表法分为治疗组和对照组,每组30例。治疗组采用中药雾化吸入与化疗结合治疗,对照组单纯用化疗治疗。观察治疗前后原发病灶疗效、KPS评分、骨髓抑制情况及胃肠反应等毒副反应发生情况。结果治疗后治疗组卡氏评分比对照组高(P<0.05);白细胞、血红蛋白、血小板下降较对照组下降程度轻,例次相对少(P<0.05)。结论中药雾化吸入配合化疗治疗NSCLC,在生活质量、减轻化疗毒副反应等方面优于单纯化疗。 Objective To investigate the effect of TCM ultrasonic nebulized inhalation combined with chemothera- py for non-small cell lung cancers (NSCLC). Methods NSCLC patients were randomized into two groups: study group which received TCM ultrasonic nebulized inhalation combined with chemotherapy, and control group which received chemotherapy. The clinical efficacy of primary lesion, the score of KPS and the major toxic effects were detected. Results After treatment, the score of KPS in study group was higher than that of control group(P〈0.05). The fall degree of WBC, Hb, PLT in study group was lighter than that of control group. Conclusion TCM ultrasonic nebulized inhalation combined with chemotherapy for NSCLC is better than chemotherapy in quality of life and alleviating the major toxic effects.
出处 《西部医学》 2012年第11期2129-2130,2133,共3页 Medical Journal of West China
关键词 非小细胞肺癌 中药雾化 治疗 Non-small cell lung cancers TCM ultrasonic nebulized inhalation Treatment
  • 相关文献

参考文献5

  • 1孙燕 周际昌.临床肿瘤内科手册[M].北京:人民卫生出版社,1996.138.
  • 2国家药品监督管理局.中药新药临床研究指导原则[S].,2002.73-75.
  • 3周际昌.实用肿瘤内科学[M].北京:第2版.人民卫生出版社,2008:34-47.
  • 4宋淑珍,田亚平,汪德清,王玲,姜辉,董矜,张阳东.黄芪多糖对健康体检者淋巴细胞亚群的调节作用[J].中国临床康复,2005,9(11):130-131. 被引量:34
  • 5徐汉琴.当归的药理作用研究进展.中华现代临床医学杂志,2007,5(11):29-29.

二级参考文献8

  • 1Bykovskaya SN, Abronina IF, Kupriyanova TA, et al. Down-regulation of LAK cell-mediated cytotoxicity: cancer and ageing. Biomed Pharmacother 1990; 44(6): 333-8.
  • 2Fridkis-Hareli M, Reinherz EL. New approaches to eliciting protective immunity through T cell repertoire manipulation: the concept of thymic vaccination. Med Immunol 2004; 3 (1): 2.
  • 3Lodoen MB, Lanier LL. Viral modulation of NK cell immunity. Nat Rev Microbiol 2005; 3 (1): 59-69.
  • 4Cormary C, Gonzalez R, Faye JC, et al. Induction of T-cell antitumor immunity and protection against tumor growth by secretion of soluble human CD70 molecules. Cancer Gene Ther 2004; 11 (7): 497-507.
  • 5Shevde LA, Joshi NN, Advani SH, et al. Impaired T lymphocyte function and differential cytokine response pattern in members from cancer families. Nat Immun 1998; 16(4): 146-56.
  • 6Von Bergwelt-Baildon M, Maecker B, Schultze J, et al. CD40 activation: potential for specific immunotherapy in B-CLL. Ann Oncol 2004; 15 (6): 853-7.
  • 7Jensen M, Tawadros S, Sedlacek HH. NK cell depletion diminish tumour-specific B cell responses. Immunol Lett 2004; 93 (2-3): 205-10.
  • 8Sako T, Burioka N, Yasuda K, et al. Cellular immune profile in patients with non-small cell lung cancer after weekly paclitaxel therapy. Acta Oncol 2004; 43(1): 15-9.

共引文献210

同被引文献25

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部